Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment

por Ataei-Nakhaei, Saeideh, Aryana, Kamran, Mostafavi, Sayyed Mostafa, Kosari, Hadis Mohammadzadeh, Esmatinia, Mohammad, Aghaee, Atena
Publicado 2022